血管免疫母细胞性T细胞淋巴瘤的临床试验
总计6859个结果
-
Institute of Hematology & Blood Diseases HospitalCancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing GD Initiative Cell...未知
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.未知
-
Peking Union Medical College Hospital招聘中
-
Ruijin HospitalThe First Affiliated Hospital of Anhui Medical University; The First Affiliated Hospital of... 和其他合作者招聘中
-
Sun Yat-sen University招聘中
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.完全的
-
University of Michigan Rogel Cancer CenterBristol-Myers Squibb完全的
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.终止
-
HUYABIO International, LLC.Quintiles, Inc.完全的
-
University of BirminghamPfizer; Bloodwise完全的
-
Acrotech Biopharma Inc.Axis Clinicals Limited完全的
-
Yuankai Shi未知
-
TetraLogic PharmaceuticalsPPD; The Leukemia and Lymphoma Society; Veristat, Inc.; Therapeutics, Inc.完全的
-
University of AarhusNordic Lymphoma Group完全的
-
McGill University未知
-
Eisai Inc.National Cancer Institute (NCI); Tufts Medical Center; Ligand Pharmaceuticals完全的
-
University of Texas Southwestern Medical Center撤销
-
University of BirminghamCelgene; Amgen; Bloodwise完全的
-
National Cancer Centre, SingaporeBristol-Myers Squibb撤销
-
Janssen Research & Development, LLC完全的淋巴瘤,T细胞,皮肤法国, 英国, 西班牙, 葡萄牙, 美国, 德国
-
The Lymphoma Academic Research Organisation完全的
-
Chonnam National University HospitalKyungpook National University Hospital未知
-
Samsung Medical CenterAsan Medical Center; Yonsei University; Seoul National University; Chonnam National University完全的
-
Peking University First HospitalPeking University Third Hospital; Peking University Cancer Hospital & Institute招聘中
-
TG Therapeutics, Inc.SCRI Development Innovations, LLC完全的